| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10469116 | Journal of Psychosomatic Research | 2015 | 6 Pages |
Abstract
Mood and substance use disorders co-occur frequently among patients with BED. Compared with a previous work, the additional comparison group (those with both mood and substance use disorders) and the control group (those with neither) afforded better discrimination regarding the significance of these comorbidities. Our findings suggest approaches to subtyping BED based on psychiatric comorbidity, and may also have implications for treatment.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Daniel F. Becker, Carlos M. Grilo,